| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 06/12/2003 | US20030108937 Methods and compositions for the diagnosis and treatment of cellular proliferation disorders using 20750 |
| 06/12/2003 | US20030108936 RecA assisted detection of mutations, single nucleotide polymorphisms and specific sequences |
| 06/12/2003 | US20030108935 Probing binding interactions between molecules and nucleic acids by unzipping a nucleic acid molecule double helix |
| 06/12/2003 | US20030108933 Novel serine-threonine kinase-3 |
| 06/12/2003 | US20030108932 Ras guanine-nucleotide-exchange factor 1 (nrg1) |
| 06/12/2003 | US20030108930 Method of evaluating drug efficacy and toxicity |
| 06/12/2003 | US20030108928 MID 241 receptor, a novel G-protein coupled receptor |
| 06/12/2003 | US20030108926 Using biochip; determination binding, calibration |
| 06/12/2003 | US20030108925 Microarray; Dna detector; detection, calibration sample fingerprints |
| 06/12/2003 | US20030108924 Isolated polynucleotide; determination genotype; analyzing |
| 06/12/2003 | US20030108923 Blocking gene expression |
| 06/12/2003 | US20030108921 Detection of rpoB sequences of Mycobacterium tuberculosis |
| 06/12/2003 | US20030108920 Tumor suppressor-like proteins that bind IGFBP2 |
| 06/12/2003 | US20030108919 Polymerase chain reaction; annealing primers; calibration using computer codes |
| 06/12/2003 | US20030108917 Three-dimensional structure; surface sensitivity; analyzing genes |
| 06/12/2003 | US20030108915 Cancer detection; using nucleotide sequence detector; calibration |
| 06/12/2003 | US20030108913 Amplification; polymerase chain reactions; mixture of nucleic acids |
| 06/12/2003 | US20030108910 Detecting nucleic acid in sample; calibrating genome |
| 06/12/2003 | US20030108907 Nucleic acids, proteins, and antibodies |
| 06/12/2003 | US20030108906 Signal transduction, gene expression of pain sequences; genetic engineering |
| 06/12/2003 | US20030108903 Immobilization on solid supports; fluorescence labels |
| 06/12/2003 | US20030108902 Generation of single-strand circular DNA from linear self-annealing segments |
| 06/12/2003 | US20030108901 Serological test for ISAV in fish |
| 06/12/2003 | US20030108900 Immobilization; amplification, genotype; detecting infections |
| 06/12/2003 | US20030108899 Detection hybrids; masking biosynthesis; photosensitive blocking agents; determination accumulated fluorescence radiation |
| 06/12/2003 | US20030108898 Method for detection, quantitation and breakpoint cluster region determination of fusion transcripts |
| 06/12/2003 | US20030108897 Analyzing target nucleic acids using oligonucleotide detector; hybrid cycles |
| 06/12/2003 | US20030108896 Method for detection of melanoma |
| 06/12/2003 | US20030108895 Analyzing cell differentaition of stem cells; drug screening |
| 06/12/2003 | US20030108890 Such as analysis of guanylate cyclase levels for progression of colon cancer; cell differentiation |
| 06/12/2003 | US20030108888 Breast cancer antigens |
| 06/12/2003 | US20030108887 Zinc finger proteins; genomes |
| 06/12/2003 | US20030108885 Methods and compositions for the production of orthogonal tRNA-aminoacyltRNA synthetase pairs |
| 06/12/2003 | US20030108884 Method and kit |
| 06/12/2003 | US20030108882 Nucleic acid encoding a retinoblastoma binding protein (RBP-7) and polymorphic markers associated with said nucleic acid |
| 06/12/2003 | US20030108881 Method for identifying mycobacterium tuberculosis and mycobacteria other than tuberculosis, together with detecting resistance to an antituberculosis drug of mycobateria obtained by mutation of rpoB gene |
| 06/12/2003 | US20030108878 DNA chip and its preparation |
| 06/12/2003 | US20030108877 Methods for selecting and producing selective pharmaceutical compounds and compositions using an established genetically altered cell-based library responsive to transcription factors; genetic constructs and library therefor. |
| 06/12/2003 | US20030108875 A primer sequence (oligonucleotide sequence or probe)that can be used to amplify (flagellin) FlaA gene in the Borrelia burgdorferi gene encodes the flagellin protein |
| 06/12/2003 | US20030108874 Compositions and systems for identifying and comparing expressed genes (mRNAs) in eukaryotic organisms |
| 06/12/2003 | US20030108873 Systems for the detection of target sequences |
| 06/12/2003 | US20030108872 Genomics-assisted rapid identification of targets |
| 06/12/2003 | US20030108871 Genes expressed in treated human C3A liver cell cultures |
| 06/12/2003 | US20030108870 DNA amplification with a first primer having a random sequence of nucleotides at its 3'end and a generic sequence 5' of the random nucleotides, as well as a second primer with the generic sequence of the first primer |
| 06/12/2003 | US20030108869 Leucine zipper domains of reporter molecule hydrolyze penicillin or cephalosporin substrates; gene expression |
| 06/12/2003 | US20030108867 Nucleic acid sequencing using microsphere arrays |
| 06/12/2003 | US20030108866 Peptide-nucleic acid (PNA) probes; amplification products; cervical scraping analysis/cancer diagnosis |
| 06/12/2003 | US20030108865 Polymerase chain reactions; DNA electrophoresis |
| 06/12/2003 | US20030108864 Detection of viable agents |
| 06/12/2003 | US20030108862 Genetic probes for hepatitis C virus (HCV) polymerase |
| 06/12/2003 | US20030108857 Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS |
| 06/12/2003 | US20030108554 GIPs, a family of polypeptides with transcription factor activity that interact with goodpasture antigen binding protein |
| 06/12/2003 | US20030108526 Gene expression marking |
| 06/12/2003 | US20030108518 TRX1 antibody and uses therefor |
| 06/12/2003 | US20030108484 Individualization of therapy with antineoplastic agents |
| 06/12/2003 | US20030108483 Non-invasive localization of a light-emitting conjugate in a mammal |
| 06/12/2003 | US20030108452 Method and device for withdrawing suspended microparticles from a fluidic microsystem |
| 06/12/2003 | US20030106810 Quantitative analysis using electroytic cell; aqueous solution containing sampling; medical diagnosis |
| 06/12/2003 | CA2473883A1 Alloiococcus otitidis open reading frames (orfs) encoding polypeptide antigens, immunogenic compositions and uses thereof |
| 06/12/2003 | CA2470508A1 Library screening |
| 06/12/2003 | CA2469568A1 A method for identifying markers |
| 06/12/2003 | CA2469477A1 Phenotypic screen of chimeric proteins |
| 06/12/2003 | CA2469403A1 Protein arrays for allelic variants and uses thereof |
| 06/12/2003 | CA2469356A1 Nuclear protein "shoca" - a component of the wnt signalling pathway |
| 06/12/2003 | CA2469196A1 Discovery of therapeutic products |
| 06/12/2003 | CA2469151A1 Immunocytokines with modulated selectivity |
| 06/12/2003 | CA2469104A1 Minor histocompatibility antigen ha-1: target antigen for immunotherapy of tumors |
| 06/12/2003 | CA2469066A1 Labelled nucleotides |
| 06/12/2003 | CA2468991A1 Methods and reagents for diagnosis and treatment of diabetes |
| 06/12/2003 | CA2468961A1 Method for the identification of genetic features for complex genetics classifiers |
| 06/12/2003 | CA2468907A1 Effectors of innate immunity |
| 06/12/2003 | CA2468851A1 Gips, a family of polypeptides with transcription factor activity that interact with goodpasture antigen binding protein |
| 06/12/2003 | CA2468743A1 Direct write nanolithographic deposition of nucleic acids from nanoscopic tips |
| 06/12/2003 | CA2468713A1 Multiplex real-time quantitative pcr |
| 06/12/2003 | CA2468710A1 Chromosomal saturation mutagenesis |
| 06/12/2003 | CA2468701A1 T-bet compositions and methods of use thereof |
| 06/12/2003 | CA2468457A1 Enzyme activity profiles |
| 06/12/2003 | CA2468432A1 Nucleotide analogues and their use for nucleic acid sequencing |
| 06/12/2003 | CA2468407A1 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
| 06/12/2003 | CA2468144A1 Information processing system using information on base sequence |
| 06/12/2003 | CA2467814A1 Multiplexed methylation detection methods |
| 06/12/2003 | CA2467587A1 Microfluidic device and methods of using same |
| 06/12/2003 | CA2467333A1 Methods for monitoring amyotrophic lateral sclerosis |
| 06/12/2003 | CA2467073A1 Peptides and method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases |
| 06/11/2003 | EP1318407A1 Use of aldose-1-epimerase (mutarotase) for the diagnosis and therapy of infections and sepsis |
| 06/11/2003 | EP1318406A1 Use of Glycine-N-Acyl-Transferase (GNAT) for diagnosis and therapy of inflammatory diseases and sepsis |
| 06/11/2003 | EP1318396A1 Biosensor |
| 06/11/2003 | EP1318203A2 Method for the amplification of nucleic acids based on elongation and displacement |
| 06/11/2003 | EP1318202A1 Method of diagnosing osteoporosis and/or estimating risk of osteoporosis fracture |
| 06/11/2003 | EP1318193A2 D-amidase from Variovorax |
| 06/11/2003 | EP1318154A1 Compounds for determination of the activity of phospholipase A2 |
| 06/11/2003 | EP1317927A1 Minor histocompatibility antigen HA-1: target antigen for immunotherapy of tumors |
| 06/11/2003 | EP1317672A2 Method for measuring the activity of the blood clotting factor xiiia |
| 06/11/2003 | EP1317669A2 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators |
| 06/11/2003 | EP1317570A2 Pcr reaction mixture for fluorescence-based gene analysis and gene mutation analysis |
| 06/11/2003 | EP1317568A2 Method of sequencing dna |
| 06/11/2003 | EP1317567A2 Genetic loci indicative of propensity for longevity and methods for identifying propensity for age-related disease |
| 06/11/2003 | EP1317566A2 Single primer pcr amplification of rna |
| 06/11/2003 | EP1317565A2 Method for controlling the microbiological quality of an aqueous medium and kit therefor |
| 06/11/2003 | EP1317564A2 Screening methods to identify g-proteins and other compounds which modulate phosphodiesterase (pde) activity |